Grantham, Mayo, Van Otterloo & Co (GMO)’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-244,050	Closed	-$9.6M	–	727
2023 Q2	$9.6M	Buy	+244,050	New	+$8.61M	0.04%	261

Grantham, Mayo, Van Otterloo & Co (GMO)'s ISEE Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 244,050 shares — an estimated $9.6M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ISEE in Q2 2023 and held it in 1 quarter. The position peaked at $9.6M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 244,050 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $9.6M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in IVERIC bio, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Grantham, Mayo, Van Otterloo & Co (GMO)'s IVERIC bio, Inc. Common Stock position peaked at $9.6M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.